Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 10Venous Thromboembolism 7Venous Thrombosis 3Treatment of Venous Thromboembolism in Cancer Patients 3Pulmonary Embolism 3Upper Extremity Deep Vein Thrombosis 2Thrombosis 1Recurrence 1Prevention of Venous Thromboembolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Myeloproliferative Disorders 1Lung Neoplasms 1Hemorrhage 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Rivaroxaban 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Upper Extremity Deep Vein Thrombosis × Rivaroxaban × Clear all
NCT03506815 2024-07-05

TRIM-Line

Ottawa Hospital Research Institute

Phase 3 Completed
105 enrolled 15 charts

Neoplasms, Upper Extremity Deep Vein Thrombosis

NCT01708850 2016-09-08

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

London Health Sciences Centre

Phase 4 Completed
70 enrolled

Neoplasms, Upper Extremity Deep Vein Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡